Orange Book product
DOXAZOSIN MESYLATE EQ 4MG BASE
Orange Book ANDA 209013 · SOMERSET THERAPEUTICS LLC · Prescription
Key facts
| Proprietary name | DOXAZOSIN MESYLATE |
|---|---|
| Active ingredients | DOXAZOSIN MESYLATE |
| Strength | EQ 4MG BASE |
| Dosage form | TABLET |
| Route | ORAL |
| Application | ANDA209013 |
| Applicant holder | SOMERSET THERAPEUTICS LLC |
| Marketing status | Prescription |
| Therapeutic equivalence (TE) code | AB |
| Reference listed drug (RLD) | No |
| Reference standard (RS) | No |
| Approval date | Apr 17, 2018 |
At a glance
- 10–99 Marketed products with the same ingredient, strength and form
- 1–9 Products in this application
- No Reference listed drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Orange Book products
The FDA Orange Book lists approved drug products with their therapeutic equivalence (TE) codes, reference listed drugs and marketing status. Products approved before 1982 show an approval date of Jan 1, 1982.